Stockscreener 앱 받기
193.22
1.18%
2.26
전일 마감가:
$190.96
열려 있는:
$188.09
하루 거래량:
2.55M
Relative Volume:
1.14
시가총액:
$40.84B
수익:
$447.02M
순이익/손실:
$-1.18B
주가수익비율:
-31.26
EPS:
-6.1812
순현금흐름:
$-906.14M
1주 성능:
+1.86%
1개월 성능:
+19.73%
6개월 성능:
+194.50%
1년 성능:
+171.15%
1일 변동 폭
$187.55
$197.44
1주일 범위
$185.69
$197.44
52주 변동 폭
$60.40
$197.44
Insmed Inc Stock (INSM) Company Profile
명칭
Insmed Inc
전화
908-977-9900
주소
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
INSM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-28 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-10-20 | 개시 | Wells Fargo | Overweight |
| 2025-08-20 | 개시 | William Blair | Outperform |
| 2025-08-13 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | 개시 | Jefferies | Buy |
| 2025-02-25 | 개시 | RBC Capital Mkts | Outperform |
| 2024-04-23 | 개시 | Truist | Buy |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-07-26 | 개시 | Guggenheim | Buy |
| 2022-12-09 | 개시 | Mizuho | Buy |
| 2022-12-07 | 개시 | Barclays | Overweight |
| 2022-11-18 | 개시 | BofA Securities | Buy |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2021-12-06 | 개시 | JP Morgan | Overweight |
| 2021-10-19 | 재개 | Monness Crespi & Hardt | Buy |
| 2021-10-19 | 재개 | Morgan Stanley | Overweight |
| 2021-10-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-10-12 | 재개 | Stifel | Buy |
| 2019-09-03 | 개시 | Goldman | Buy |
| 2019-04-09 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-15 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-01-02 | 개시 | Canaccord Genuity | Buy |
| 2018-08-06 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | 개시 | Goldman | Neutral |
| 2018-04-23 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | 개시 | Morgan Stanley | Overweight |
| 2018-01-18 | 개시 | Credit Suisse | Neutral |
| 2017-09-05 | 재확인 | Evercore ISI | Outperform |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-07-11 | 개시 | Robert W. Baird | Outperform |
| 2016-03-15 | 개시 | Stifel | Buy |
| 2015-11-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2015-10-06 | 재확인 | H.C. Wainwright | Buy |
| 2015-06-09 | 개시 | Citigroup | Neutral |
| 2014-03-26 | 재확인 | HC Wainwright | Buy |
모두보기
Insmed Inc 주식(INSM)의 최신 뉴스
Insmed stock reaches 52-week high at 197.1 USD By Investing.com - Investing.com Nigeria
Building trade automation scripts for Insmed Incorporated2025 Price Momentum & Target Return Focused Stock Picks - newser.com
What machine learning models say about Insmed IncorporatedPortfolio Growth Summary & Expert Approved Momentum Ideas - newser.com
Trend analysis for Insmed Incorporated this weekJuly 2025 News Drivers & Expert Approved Momentum Trade Ideas - newser.com
Why Insmed Incorporated is moving todayJuly 2025 Market Mood & AI Powered Market Entry Strategies - newser.com
Insmed (NASDAQ: INSM) holds fourth Global Day of Good with 1,200+ volunteers worldwide - Stock Titan
Will Insmed Incorporated stock benefit from automationJuly 2025 Trends & Real-Time Market Sentiment Alerts - newser.com
How Insmed Incorporated (IM8N) stock compares with tech leadersMarket Risk Analysis & Free Real-Time Market Sentiment Alerts - newser.com
Officer Flammer Files To Sell 31,226 Of Insmed Inc [INSM] - TradingView
[Form 4] INSMED Inc Insider Trading Activity - Stock Titan
How Insmed Incorporated stock reacts to Fed rate cutsWeekly Profit Recap & Stock Market Timing Techniques - newser.com
Insmed's chief medical officer sells $2.97 million in stock - MSN
Historical volatility pattern of Insmed Incorporated visualizedWeekly Risk Summary & Daily Oversold Bounce Ideas - newser.com
Insmed Incorporated (NASDAQ:INSM) Q1 2025 Earnings Call Transcript - MSN
Is Insmed Incorporated (IM8N) stock a buy before new product rolloutProfit Target & Free Growth Oriented Trading Recommendations - newser.com
What dividend safety score for Insmed Incorporated stockPortfolio Growth Summary & Fast Gaining Stock Reports - newser.com
Can Insmed Incorporated (IM8N) stock sustain institutional flows2025 AllTime Highs & Daily Oversold Stock Bounce Ideas - fcp.pa.gov.br
Will Insmed Incorporated (IM8N) stock see valuation expansionPortfolio Risk Summary & Verified Entry Point Signals - newser.com
How Insmed Incorporated (IM8N) stock performs during market turbulence2025 Macro Impact & Short-Term High Return Strategies - newser.com
Insmed Incorporated stock volume spike explained2025 Investor Takeaways & Weekly Chart Analysis and Guides - newser.com
Insmed Inc (INSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Insmed Inc 주식 (INSM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Schaeffer Orlov S Nicole | Chief People Strategy Officer |
Nov 12 '25 |
Sale |
194.00 |
30,000 |
5,820,061 |
36,461 |
| Flammer Martina M.D. | Chief Medical Officer |
Nov 11 '25 |
Option Exercise |
18.17 |
31,226 |
567,389 |
114,337 |
| Flammer Martina M.D. | Chief Medical Officer |
Nov 11 '25 |
Sale |
189.68 |
31,226 |
5,922,795 |
83,111 |
0.69%
1.82%
자본화:
|
볼륨(24시간):